Skip to main content

MINI REVIEW article

Front. Public Health
Sec. Digital Public Health
Volume 12 - 2024 | doi: 10.3389/fpubh.2024.1420367

The Application of Metaverse in Healthcare

Provisionally accepted
Yue Wang Yue Wang 1Ruibin Liu Ruibin Liu 1Mengying Zhu Mengying Zhu 1Jinnian Ge Jinnian Ge 2Guilin Yu Guilin Yu 1,2*
  • 1 Liaoning Cancer Hospital, China Medical University, Shenyang, China
  • 2 China Medical University, Shenyang, Liaoning Province, China

The final, formatted version of the article will be published soon.

    While Metaverse is widely discussed, comprehension of its intricacies remains limited to a select few. Conceptually akin to a three-dimensional embodiment of the Internet, the Metaverse facilitates simultaneous existence in both physical and virtual domains. Fundamentally, it embodies a visually immersive virtual environment, striving for authenticity, where individuals engage in real-world activities such as commerce, gaming, social interaction, and leisure pursuits. The global pandemic has accelerated digital innovations across diverse sectors. Beyond strides in telehealth, payment systems, remote monitoring, and secure data exchange, substantial advancements have been achieved in artificial intelligence (AI), virtual reality (VR), augmented reality (AR), and blockchain technologies. Nevertheless, the Metaverse, in its nascent stage, continues to evolve, harboring significant potential for revolutionizing healthcare. Through integration with the Internet of Medical Devices, quantum computing, and robotics, the Metaverse stands poised to redefine healthcare systems, offering enhancements in surgical precision and therapeutic modalities, thus promising profound transformations within the industry.

    Keywords: Metaverse, healthcase, virtual reality, artificial intelligence, augmented reality

    Received: 20 Apr 2024; Accepted: 10 Jul 2024.

    Copyright: © 2024 Wang, Liu, Zhu, Ge and Yu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Guilin Yu, Liaoning Cancer Hospital, China Medical University, Shenyang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.